Probiotics and synbiotics may improve liver aminotransferases levels in non-alcoholic fatty liver disease patients

Non-alcoholic fatty liver disease (NAFLD) is defined as a spectrum of liver diseases ranging from simple steatosis to steatohepatitis (NASH). Alterations in intestinal microbiota and inflammatory response may play a key role in disease progression and development of complications in liver diseases,...

Full description

Bibliographic Details
Main Authors: Caroline Buss, R.D., Ph.D., Cristiane Valle-Tovo, Suellen Miozzo, Angelo Alves de Mattos
Format: Article
Language:English
Published: Elsevier 2014-09-01
Series:Annals of Hepatology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119312463